أخبار السوق اليوم — عناوين الأسهم والعملات الرقمية المنتقاة بالذكاء الاصطناعي

Iran won't accept U.S. effort at ceasefire in war, state media reports

President Donald Trump has claimed the United States and Iran are "in negotiations now." But the Islamic Republic denies any …

Swiss sneaker maker On Holding shakes up leadership amid slowing growth

Co-founders to become co-CEOs as On prepares to enter its "next growth phase," the company said in a statement Wednesday.

Iran war may further 'chill' an already frozen job market, economist says

The war injects additional uncertainty for businesses, leading them to hit pause on hiring.

Temu parent’s stock drops as end of ‘de minimis’ import rule comes at a cost

Temu parent PDD’s stock falls after earnings miss expectations.

Legal AI startup Harvey valued at $11 billion in funding round, as VCs spread bets beyond model companies

Harvey will use its fresh capital to expand its AI agents and grow its embedded legal engineering teams.

Hugo Barra's return to Meta 5 years after exit underscores Zuckerberg's AI urgency

During Hugo Barra's first stint at Meta, the company was pushing heavily into VR. Now, he's back and the focus …

ChatGPT or Claude? How to decide which AI chatbot is worth your money.

Before subscribing to an AI bot like these — or Grok or Gemini — here’s how the top four models …

Merck makes a big move into new cancer treatments with a $6.7 billion buyout deal

Merck to spend $6.7 billion to buy Terns Pharmaceuticals, which is developing an oral treatment for leukemia.

KB Home says the war is already hurting home sales as it cuts guidance

KB Home shares were under pressure on Wednesday after saying it’s already seeing prospective buyers deterred by the war as …

What OpenAI scrapping its Sora video generator tells us about AI

The idea that anyone can develop a scaled social, video, music or marketplace business has been exaggerated, one analyst says.

Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline

Merck is trying to bulk up its portfolio ahead of its best-selling cancer drug Keytruda losing patent protection in 2028.

Mortgage demand drops more than 10% as rates hit the highest level since October

Mortgage demand continued to tumble last week, as mortgage rates surged higher and affordability weakened further.